Transcripta Bio Secures $24M to Pioneer Transcriptome-Based Drug Discovery
In the high-stakes arena of modern pharmaceutical research, where the attrition rate for new drug candidates often exceeds 90%, a...
In the high-stakes arena of modern pharmaceutical research, where the attrition rate for new drug candidates often exceeds 90%, a...
In a groundbreaking study that challenges our fundamental understanding of oncology and evolutionary biology, researchers from the University of Vermont...
In a significant move that bridges the gap between extracellular matrix (ECM) biology and advanced bioconjugation chemistry, Lonza and Engitix...
In the complex architectural landscape of the human brain, structural integrity is paramount. Neurons rely on an intricate internal framework...
California, long celebrated as the "Golden State" for its historical abundance and economic vitality, is increasingly staking a claim to...
In the landscape of modern oncology, few challenges are as persistent as the "gray areas" of diagnostic pathology. For patients...
In a strategic evolution that marks a departure from its foundational role as a provider of research-grade tools, 10x Genomics...
In an era where the pace of drug discovery is dictated as much by data processing as it is by...
In a landmark achievement for molecular biology, researchers at EMBL Hamburg and the Leibniz Research Institute for Molecular Pharmacology (FMP)...
For over two decades, the global health community has operated under a singular, powerful premise: mass drug administration (MDA) with...
For decades, the conventional wisdom in neuroscience suggested that the human brain reached its architectural maturity by the time an...
Executive Summary: A Strategic Expansion in the Heart of Europe In a move designed to fortify the European biopharmaceutical supply...